FRESENIUS SE & CO KGAA (FRE.DE) Fundamental Analysis & Valuation

FRA:FRE • DE0005785604

Current stock price

45.035 EUR
+0.53 (+1.2%)
Last:

This FRE.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. FRE.DE Profitability Analysis

1.1 Basic Checks

  • In the past year FRE was profitable.
  • In the past year FRE had a positive cash flow from operations.
  • FRE had positive earnings in 4 of the past 5 years.
  • Of the past 5 years FRE 4 years had a positive operating cash flow.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

1.2 Ratios

  • FRE has a Return On Assets (2.69%) which is in line with its industry peers.
  • FRE has a Return On Equity (6.14%) which is comparable to the rest of the industry.
  • The Return On Invested Capital of FRE (4.44%) is worse than 62.07% of its industry peers.
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROIC 4.44%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.11%, FRE belongs to the top of the industry, outperforming 89.66% of the companies in the same industry.
  • In the last couple of years the Profit Margin of FRE has grown nicely.
  • FRE has a Operating Margin of 9.76%. This is amongst the best in the industry. FRE outperforms 89.66% of its industry peers.
  • In the last couple of years the Operating Margin of FRE has declined.
  • FRE has a Gross Margin of 24.99%. This is comparable to the rest of the industry: FRE outperforms 51.72% of its industry peers.
  • In the last couple of years the Gross Margin of FRE has declined.
Industry RankSector Rank
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
OM growth 3Y5.78%
OM growth 5Y-3.42%
PM growth 3Y-4.64%
PM growth 5Y3.27%
GM growth 3Y-0.27%
GM growth 5Y-2.63%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. FRE.DE Health Analysis

2.1 Basic Checks

  • FRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for FRE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 2.01 indicates that FRE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.01, FRE is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
  • FRE has a debt to FCF ratio of 11.17. This is a negative value and a sign of low solvency as FRE would need 11.17 years to pay back of all of its debts.
  • FRE has a Debt to FCF ratio of 11.17. This is comparable to the rest of the industry: FRE outperforms 41.38% of its industry peers.
  • FRE has a Debt/Equity ratio of 0.61. This is a neutral value indicating FRE is somewhat dependend on debt financing.
  • FRE's Debt to Equity ratio of 0.61 is amongst the best of the industry. FRE outperforms 86.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Altman-Z 2.01
ROIC/WACC0.85
WACC5.23%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • FRE has a Current Ratio of 1.26. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
  • FRE's Current ratio of 1.26 is fine compared to the rest of the industry. FRE outperforms 68.97% of its industry peers.
  • A Quick Ratio of 0.99 indicates that FRE may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.99, FRE is in the better half of the industry, outperforming 72.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.99
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. FRE.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.31% over the past year.
  • Measured over the past years, FRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.06% on average per year.
  • Looking at the last year, FRE shows a small growth in Revenue. The Revenue has grown by 3.87% in the last year.
  • FRE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.81% yearly.
EPS 1Y (TTM)6.31%
EPS 3Y9.46%
EPS 5Y-0.06%
EPS Q2Q%-25%
Revenue 1Y (TTM)3.87%
Revenue growth 3Y2.03%
Revenue growth 5Y-8.81%
Sales Q2Q%5.88%

3.2 Future

  • FRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.54% yearly.
  • The Revenue is expected to grow by 5.03% on average over the next years.
EPS Next Y16.18%
EPS Next 2Y13.43%
EPS Next 3Y11.88%
EPS Next 5Y10.54%
Revenue Next Year5%
Revenue Next 2Y4.97%
Revenue Next 3Y4.97%
Revenue Next 5Y5.03%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. FRE.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.07, which indicates a correct valuation of FRE.
  • 68.97% of the companies in the same industry are more expensive than FRE, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, FRE is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 12.11, FRE is valued correctly.
  • Based on the Price/Forward Earnings ratio, FRE is valued a bit cheaper than 75.86% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of FRE to the average of the S&P500 Index (23.68), we can say FRE is valued slightly cheaper.
Industry RankSector Rank
PE 14.07
Fwd PE 12.11
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as FRE.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of FRE indicates a slightly more expensive valuation: FRE is more expensive than 65.52% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.16
EV/EBITDA 9.77
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.87
PEG (5Y)N/A
EPS Next 2Y13.43%
EPS Next 3Y11.88%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. FRE.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.40%, FRE has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.93, FRE pays a bit more dividend than its industry peers.
  • FRE's Dividend Yield is a higher than the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.4%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2016 2019 2020 2021 2022 2023 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 59.84% of the earnings are spent on dividend by FRE. This is a bit on the high side, but may be sustainable.
DP59.84%
EPS Next 2Y13.43%
EPS Next 3Y11.88%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FRE.DE Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS SE & CO KGAA

FRA:FRE (4/10/2026, 4:25:17 PM)

45.035

+0.53 (+1.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)05-06
Inst Owners45.33%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap25.37B
Revenue(TTM)22.68B
Net Income(TTM)1.14B
Analysts85.22
Price Target57.32 (27.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.4%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP59.84%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.22%
Min EPS beat(2)8.91%
Max EPS beat(2)13.53%
EPS beat(4)4
Avg EPS beat(4)13.17%
Min EPS beat(4)8.91%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)-25.39%
EPS beat(12)7
Avg EPS beat(12)-39.44%
EPS beat(16)8
Avg EPS beat(16)-31.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.27%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)1.68%
PT rev (3m)3.67%
EPS NQ rev (1m)-0.19%
EPS NQ rev (3m)2.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.72%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)0.23%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.35%
Valuation
Industry RankSector Rank
PE 14.07
Fwd PE 12.11
P/S 1.14
P/FCF 21.16
P/OCF 11.65
P/B 1.36
P/tB 13.7
EV/EBITDA 9.77
EPS(TTM)3.2
EY7.11%
EPS(NY)3.72
Fwd EY8.26%
FCF(TTM)2.13
FCFY4.73%
OCF(TTM)3.87
OCFY8.58%
SpS39.68
BVpS33.06
TBVpS3.29
PEG (NY)0.87
PEG (5Y)N/A
Graham Number48.79
Profitability
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROCE 6.63%
ROIC 4.44%
ROICexc 5.05%
ROICexgc 11.76%
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
FCFM 5.37%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y5.78%
OM growth 5Y-3.42%
PM growth 3Y-4.64%
PM growth 5Y3.27%
GM growth 3Y-0.27%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Debt/EBITDA 3.4
Cap/Depr 86.4%
Cap/Sales 4.38%
Interest Coverage 6.84
Cash Conversion 65.69%
Profit Quality 104.9%
Current Ratio 1.26
Quick Ratio 0.99
Altman-Z 2.01
F-Score7
WACC5.23%
ROIC/WACC0.85
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.31%
EPS 3Y9.46%
EPS 5Y-0.06%
EPS Q2Q%-25%
EPS Next Y16.18%
EPS Next 2Y13.43%
EPS Next 3Y11.88%
EPS Next 5Y10.54%
Revenue 1Y (TTM)3.87%
Revenue growth 3Y2.03%
Revenue growth 5Y-8.81%
Sales Q2Q%5.88%
Revenue Next Year5%
Revenue Next 2Y4.97%
Revenue Next 3Y4.97%
Revenue Next 5Y5.03%
EBIT growth 1Y51.21%
EBIT growth 3Y7.94%
EBIT growth 5Y-11.93%
EBIT Next Year54.49%
EBIT Next 3Y20.57%
EBIT Next 5Y14.27%
FCF growth 1Y-43.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.77%
OCF growth 3YN/A
OCF growth 5YN/A

FRESENIUS SE & CO KGAA / FRE.DE Fundamental Analysis FAQ

What is the fundamental rating for FRE stock?

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.


What is the valuation status for FRE stock?

ChartMill assigns a valuation rating of 4 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Fairly Valued.


What is the profitability of FRE stock?

FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 4 / 10.


What is the valuation of FRESENIUS SE & CO KGAA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FRESENIUS SE & CO KGAA (FRE.DE) is 14.07 and the Price/Book (PB) ratio is 1.36.


How financially healthy is FRESENIUS SE & CO KGAA?

The financial health rating of FRESENIUS SE & CO KGAA (FRE.DE) is 4 / 10.